Special Issue "Marine-Derived Polyketides with Antibiotic Activity"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (15 May 2019)
Prof. Dr. Till F. Schäberle
Head of Natural Product Research, Institute for Insect Biotechnology, University of Giessen, Giessen, Germany
Website | E-Mail
Interests: natural products isolation and characterization; bioassay-guided purification of natural products/drug discovery; isolation of natural product producing bacteria; bioinformatics; analysis of biosynthetic gene clusters; metagenomics
Polyketides are a class of specialized metabolites produced by a wide variety of organisms. Most intriguing is the fact that these compounds show a multitude of biological activities, e.g., antibacterial activities. They are in the focus of research from an ecological, as well as pharmaceutical point of view, since many medicinal drugs are natural polyketides per se, or are based on them. Hence, polyketides possess the potential to become leads for novel medicinal drugs. Especially in the antibiotics field exists a pressing need to identify and evaluate novel structures. The current drugs, contributing to the increased life expectancy of humans, are losing their power due to antimicrobial resistance development and dispersion.
The goal of this Marine Drugs Special Issue is to assemble a collection of scientific articles outlining the diversity, the biosynthesis and the antibiotic potential of marine-derived polyketides.
Scientists from various fields are invited to contribute, to combine interdisciplinary expertise in marine-derived polyketides research, e.g., (micro)biology, analytical chemistry, bioinformatics, pharmacy, and biotechnology.
Prof. Dr. Till F. Schäberle
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Mixed PKS/NRPS
- natural product
- secondary metabolite
- specialized metabolite